First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT)

CUSIP: 33733E203

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
Shares outstanding
11,300,576
Total 13F shares
6,096,208
Share change
-193,817
Total reported value
$959,021,765
Price per share
$157.26
Number of holders
210
Value change
-$32,144,151
Number of buys
89
Number of sells
102

Quarterly Holders Quick Answers

What is CUSIP 33733E203?
CUSIP 33733E203 identifies FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q3 2020

As of 30 Sep 2020, First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by 210 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,096,208 shares. The largest 10 holders included MORGAN STANLEY, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, UBS Group AG, LPL Financial LLC, Raymond James Financial Services Advisors, Inc., ROYAL BANK OF CANADA, RAYMOND JAMES & ASSOCIATES, ADVISOR GROUP HOLDINGS, INC., and COMMONWEALTH EQUITY SERVICES, LLC. This page lists 210 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
222
Q3 2020 holders
210
Holder diff
-12
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .